At the start of the year, UBM increases total output by more than 20 percent to 86 million euros. EBIT in the first quarter was EUR 41.7 million, compared to EUR 12.5 million in the previous year. The bottom line is UBM’s profit of EUR 20.5 million, a clear plus compared to the EUR 4.1 million from the previous year.
From the second quarter, UBM should feel the effects of Corona. However, SRC Research analysts think UBM is well positioned, and strategic adjustments have been made quickly. The company’s cash holdings of EUR 190 million are considered very comfortable.
The experts are very satisfied with the first quarter of the Austrians, the same applies to setting the course. Therefore, they confirm the purchase recommendation for the UBM papers. As before, the target price is EUR 44.00.
The UBM shares today gain 2.4 percent to EUR 37.60. Before the crisis, the share was trading at almost 50 euros, so there is still more catching up to do for the title.
At a glance – chart and news: UBM Development